| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 18.388.068 $ | +1.591.263 $ | +169,4 % | 8 | 18.191.302 $ | +2.851.362 $ | +402,9 % | 7 | 25.281.897 $ | +25.124.498 $ | +2.157,2 % | 10 | ||||
| iSHARES TRUST | → 0 | 2.531.400 $ | -74.677 $ | -2,9 % | 1 | 2.606.077 $ | -1.547.322 $ | -37,3 % | 1 | 4.153.399 $ | +4.153.399 $ | 1 | |||
| ISHARES TR | → 0 | 2.284.285 $ | +2.127.471 $ | +1.356,7 % | 1 | 3.365.361 $ | +3.249.520 $ | +2.805,2 % | 1 | 3.552.745 $ | +3.395.346 $ | +2.157,2 % | 1 | ||
| INVESCO EXCHANGE-TRADED FUND TRUST | → 0 | 1.874.984 $ | -1.153.011 $ | -38,1 % | 1 | 3.027.995 $ | +825.988 $ | +37,5 % | 1 | 2.202.007 $ | +2.202.007 $ | 1 | |||
| GILEAD SCIENCES, INC. | GILD | → 0 | Stark | 2.580.621 $ | -243.015 $ | -8,6 % | 1 | 2.823.636 $ | +152.691 $ | +5,7 % | 1 | 2.670.945 $ | +2.670.945 $ | 1 | |
| Invitation Homes Inc. | INVH | → 0 | Neutral | 2.205.330 $ | +391.280 $ | +21,6 % | 1 | 2.501.100 $ | +2.501.100 $ | 1 | |||||
| VERTEX PHARMACEUTICALS INC / MA | VRTX | → 0 | Schwach | 2.484.643 $ | +282.754 $ | +12,8 % | 1 | 2.201.889 $ | +87.871 $ | +4,2 % | 1 | 2.114.018 $ | +2.114.018 $ | 1 | |
| iShares, Inc. | → 0 | 2.266.275 $ | +315.106 $ | +16,1 % | 1 | 1.951.169 $ | -179.692 $ | -8,4 % | 1 | 2.130.861 $ | +2.130.861 $ | 1 | |||
| ASTRAZENECA PLC | AZN | → 0 | 2.160.530 $ | -54.645 $ | -2,5 % | 1 | 2.215.175 $ | +262.306 $ | +13,4 % | 1 | 1.952.869 $ | +1.952.869 $ | 1 | ||
| EURONET WORLDWIDE, INC. | EEFT | → 0 | Neutral | 2.120.044 $ | +2.120.044 $ | 1 | |||||||||
| Alpine Income Property Trust, Inc. | PINE | → 0 | Stark | 1.883.909 $ | +1.883.909 $ | 1 | |||||||||
| 18.388.068 $ | +1.591.263 $ | +169,4 % | 8 | 18.191.302 $ | +2.851.362 $ | +402,9 % | 7 | 25.281.897 $ | +25.124.498 $ | +2.157,2 % | 10 | ||||